Skip to main content
Premium Trial:

Request an Annual Quote

One More Enters the Fray

Pathway Genomics is jumping into the direct-to-consumer genetic testing market, reports Agence France Presse. According to the company website, the health test costs $249 and will genotype customers for risk markers for over 90 diseases, carrier status for some diseases, drug responses, and inheritable traits (such as eye color), while the ancestry test is $199, though both can be purchased simultaneously for $348. Pathway Genomics will also have genetic counselors on staff. "Our goal is to keep a low cost and make this test available to anyone," founder and CEO Jim Plante tells AFP. "I always felt that consumers didn't have direct access to genetic information in a way that was cost effective."

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.